Journal Report

Journal of the Neurological Sciences

Download PDF
Journal Information
Journal Title
Journal of the Neurological Sciences
Publisher
ISSN
0022-510X
E-ISSN
Database
AERES
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Paradoxical ethnic differences in prevalence of vascular risk factors versus extracranial atherosclerotic disease in TIA/stroke patients in the United Kingdom: Population-based study and meta-analysis
Joseph Kamtchum-Tatuene, Linxin Li, Peter M. Rothwell
2026-12 Vol. 491 Pages 126238
DOI: 10.1016/j.jns.2026.126238
The prognostic role of echocardiographic parameters in ischemic stroke patients with atrial fibrillation
Annaelle Zietz, Alexandros A. Polymeris, Beat A. Kaufmann et al.
2026-12 Vol. 491 Pages 126234
DOI: 10.1016/j.jns.2026.126234
A potential biomarker for the efficacy of complement inhibitors in myasthenia gravis
Etsuko Ogaya, Akiyuki Uzawa, Hiroyuki Akamine et al.
2026-12 Vol. 491 Pages 126212
DOI: 10.1016/j.jns.2026.126212
Comment on “Lower atrial fibrillation detection in cryptogenic stroke patients with patent foramen ovale: Evidence from insertable cardiac monitoring”
Haijun Chen, Mengying Hu
2026-12 Vol. 491 Pages 126189
DOI: 10.1016/j.jns.2026.126189
Prolonged Guillain-Barre´ Syndrome: longstanding demyelination and axonopathy
Francis Gerwin Jalipa, Peter Dobrowolski, Sameer Chhibber et al.
2026-12 Vol. 491 Pages 126233
DOI: 10.1016/j.jns.2026.126233
Baló's concentric sclerosis: Longitudinal analysis of 20 patients revealing a clinical phenotype distinct from multiple sclerosis
Regina M.P. Alvarenga, Débora C de Souza de Oliveira, Marina P. Alvarenga et al.
2026-12 Vol. 491 Pages 126227
DOI: 10.1016/j.jns.2026.126227
Antithrombotic use patterns for secondary stroke prevention in ischemic stroke patients with active malignancy: The STOP-SPAM study
Dylan Ryan, Tracy Truong, Michael W. Lutz et al.
2026-12 Vol. 491 Pages 126173
DOI: 10.1016/j.jns.2026.126173
Glucagon-like peptide-1 as a recovery biomarker after traumatic brain injury in patients with obesity: Preliminary results
Shawn R. Eagle, Mahesh K. Basantani, Ava Puccio et al.
2026-12 Vol. 491 Pages 126232
DOI: 10.1016/j.jns.2026.126232
Drug-coated balloon versus stent angioplasty in patients with intracranial atherosclerotic stenosis: A systematic review and meta-analysis
Aya Magdy Siam, Omar Fayez Abbas, Nour Aldin T. Ahmed et al.
2026-12 Vol. 491 Pages 126214
DOI: 10.1016/j.jns.2026.126214
Long-term outcomes of alemtuzumab in relapsing–remitting multiple sclerosis: a real-world cohort with particular focus on treatment sequencing after natalizumab
Marta Gaggiola, Valentina Annamaria Mauceri, Giovanni Zanotelli et al.
2026-12 Vol. 491 Pages 126210
DOI: 10.1016/j.jns.2026.126210
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 11, 2026 21:23